Skip to main content
Researchers discover new strategy against drug-resistant skin cancer

The existing cancer drug vorinostat has been shown to kill resistant cancer cells in skin cancer patients, according to a study published in Cell. The drug can be used on patients who have a resistance to treatment with a BRAF inhibitor.

Full Story: